The structural basis of persistent pulmonary hypertension of the newborn infant
- PMID: 7229803
- DOI: 10.1016/s0022-3476(81)80605-1
The structural basis of persistent pulmonary hypertension of the newborn infant
Abstract
Six neonates of 35 to 42 weeks' gestation had findings of persistent pulmonary hypertension and died between one and 6 days of age despite intensive medical therapy. Each patient had pulmonary artery pressure near or above systemic level, with a right-to-left shunt via the foramen ovale and/or ductus arteriosus. At postmortem, morphometric analysis of the peripheral pulmonary vascular bed revealed extension of muscle into small arteries, which was severe in five of six patients; all alveolar duct and wall arteries (less than 30 micrometers external diameter), normally nonmuscular, were fully muscularized. In these five patients medial wall thickness of the normally muscular intra-acinar arteries was doubled; arterial size and number, however, were normal in all. This striking structural maldevelopment of the peripheral pulmonary arterial bed occurred or was initiated in utero and does not merely represent a failure of the fetal pattern to regress. We suggest that this particular group of patients remained refractory to all current modes of therapy because of these severe structural pulmonary vascular changes.
Similar articles
-
Familial persistent pulmonary hypertension.Arch Dis Child. 1984 Aug;59(8):783-5. doi: 10.1136/adc.59.8.783. Arch Dis Child. 1984. PMID: 6476881 Free PMC article.
-
Histological study of pulmonary vasculature in fatal cases of persistent pulmonary hypertension of the newborn.Tohoku J Exp Med. 1991 May;164(1):59-66. doi: 10.1620/tjem.164.59. Tohoku J Exp Med. 1991. PMID: 1926147
-
Fetal hypertension and the development of increased pulmonary vascular smooth muscle: a possible mechanism for persistent pulmonary hypertension of the newborn infant.J Pediatr. 1978 Feb;92(2):265-9. doi: 10.1016/s0022-3476(78)80022-5. J Pediatr. 1978. PMID: 23421
-
Constrictive and restrictive pulmonary hypertension in the newborn and infant.Am J Cardiovasc Pathol. 1987;1(2):287-99. Am J Cardiovasc Pathol. 1987. PMID: 3333143 Review.
-
Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management.Paediatr Drugs. 2006;8(3):179-88. doi: 10.2165/00148581-200608030-00004. Paediatr Drugs. 2006. PMID: 16774297 Review.
Cited by
-
Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells.Am J Respir Cell Mol Biol. 2012 Aug;47(2):218-26. doi: 10.1165/rcmb.2011-0015OC. Epub 2012 Mar 23. Am J Respir Cell Mol Biol. 2012. PMID: 22447968 Free PMC article.
-
Persistent fetal circulation.Paediatr Child Health. 2001 Dec;6(10):744-50. doi: 10.1093/pch/6.10.744. Paediatr Child Health. 2001. PMID: 20084150 Free PMC article.
-
The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis.Front Pharmacol. 2021 Apr 23;12:668902. doi: 10.3389/fphar.2021.668902. eCollection 2021. Front Pharmacol. 2021. PMID: 33967811 Free PMC article.
-
The pulmonary circulation in neonatal respiratory failure.Clin Perinatol. 2012 Sep;39(3):655-83. doi: 10.1016/j.clp.2012.06.006. Clin Perinatol. 2012. PMID: 22954275 Free PMC article. Review.
-
Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn.Pediatrics. 2013 Jan;131(1):79-87. doi: 10.1542/peds.2012-0496. Epub 2012 Dec 3. Pediatrics. 2013. PMID: 23209104 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical